α1-Adrenergic receptor antibodies in patients with primary hypertension

Hypertension

Volumn 29, Issue 2, 1997, Pages 678-682

  Luther, Hans Peter ^a   Homuth, Volker ^a   Wallukat, Gerd ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

epitope mapping; hypertension, essential; immune system; receptors, adrenergic, alpha 1; sympathetic nervous system

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; AUTOIMMUNITY; BLOOD VESSEL INNERVATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SYMPATHETIC NERVE;

EID: 0031037595     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.2.678     Document Type: Article

References (29)

1. Dzielak D. The immune system and hypertension. Hypertension. 1992;19(suppl I):I-36-I-44.
2. Fu MLX. Do immune system changes have a role in hypertension? J Hypertens. 1995;13:1259-1265.
3. Takeichi N, Boone CW. Spontaneous rosette formation of rat thymus cells with guinea pig erythrocytes. Cell Immunol. 1976;27:52-59.
4. Takeichi N, Suzuki K, Kobayashi H. Characterization of immunological depression in spontaneously hypertensive rats. Eur J Immunol. 1981;11:483-487.
5. Suzuki T, Oboshi S, Sato R. Periarteritis nodosa in spontaneously hypertensive rats: incidence and distribution. Acta Pathol Jpn. 1979; 29:697-703.
6. Olsen F, Rasmussen S. Delayed hypersensitivity and borderline essential hypertension. Acta Pathol Microbiol Scand. 1977;85:196-199.
7. Gudbrandsson T, Herlitz H, Lindholm L, Nilsson LA, Hansson L. Immunological changes in patients with previous malignant essential hypertension. Lancet. 1981;1:406-408.
8. Ebringer A, Doyle AE. Raised serum IgG levels in hypertension. Br Med J. 1970;2:146-148.
9. Olsen F, Hilden M, Ibsen H. Raised levels of immunoglobulins in serum of hypertensive patients. Acta Pathol Microbiol Scand. 1973; 81:775-778.
10. Kristensen BO. Increased serum levels of immunoglobulins in untreated and treated essential hypertension. Acta Med Scand. 1978; 203:49-54.
11. Suryaprabha P, Padma T, Brahmaji-Rao V. Increased serum IgG levels in essential hypertension. Immunol Lett. 1984;8:143-145.
12. Kristensen BO, Solling K. Serum concentrations of immunoglobulins and free light chains before and after vascular events in essential hypertension. Acta Med Scand. 1983;13:15-20.
13. Kristensen BO, Andersen PL. Autoantibodies in untreated and treated essential hypertension. Acta Med Scand. 1978;203:55-59.
14. Almon RR, Andrew CG, Appel JH. Serum globulin in myasthenia gravis: inhibition of α-bungarotoxin binding to acetylcholine receptors. Science. 1974;186:55-57.
15. Kishihara M, Nakao Y, Baba Y, Matsukura S, Kuma K, Fujita T. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes. J Clin Endocrinol Metab. 1979;49:706-711.
16. Wallukat G, Wollenberger A. Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic β-adrenoceptor function in cultured rat heart myocytes. Biomed Biochem Acta. 1987;78:5634-5639.
17. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against β-adrenoreceptors in human dilated cardiomyopathy. Circ Res. 1989; 64:97-103.
18. 1-adrenoceptor with positive chronotropic effect. Circulation. 1994;89:2760-2767.
19. 1-adrenergic agonism without desensitization. Eur Heart J. 1991;12(suppl D):178-181.
20. 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 1990;86:1658-1663.
21. 1-adrenergic receptors in patients with malignant hypertension. Lancet. 1994;334: 1660-1663.
22. 1-adrenoceptors: consensus update. Pharmacol Rev. 1995;47:267-270.
23. 1-adrenoceptor. Biochimie. 1994;76:159-164.
24. 1-adrenergic receptor. Clin Exp Immunol. 1994;97:146-151.
25. 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes. J Clin Invest. 1990;85:1206-1214.
26. 1-adrenoceptor. J Hypertens. 1995;13:1031-1036.
27. Fu MLX, Hoebeke J, Matsui S, Matoba M, Magnusson Y, Hedner T, Herlitz H, Hjalmarson A. Autoantibodies against cardiac G-protein coupled receptor define different populations with cardiomyopathy but not with hypertension. Clin Immunol Immunopathol. 1994; 72:15-20.
28. Khraibi AA. Immunoregulatory failure in the pathophysiology of hypertension. News Physiol Sci. 1994;9:27-30.
29. Julius S, Johnson EH. Stress, autonomic hyperactivity and essential hypertension: an enigma. J Hypertens. 1985;3(suppl 4):11-17.